Pharmanovia Signs Novel Biologic In-Licensing Agreement With Lindis Biotech to Commercialise Catumaxomab for Treatment of Rare Condition, Malignant Ascites November 19, 2024
Evosep Expanding Capabilities with New Headquarters to Support Rising Needs in Pharma and Biotech for Proteomics October 21, 2024
Aurion Biotech Launches Vyznova® (neltependocel) in Japan for the Treatment of Bullous Keratopathy of the Cornea September 24, 2024
